Other names published for TOP2: TOR3, TRF3, DNA topoisomerase 2, YNL088W
TOP2 LITERATURE TOPICS
- Curated Literature
- Genetics/Cell Biology
- Nucleic Acid Information
- Gene Product Information
- Related Genes/Proteins
- Research Aids
- Genome-wide Analysis
- Proteome-wide Analysis
- Other Topics
- Additional Information
TOP2 - Function/Process (90)
| Reference | Other Genes Addressed |
|---|---|
| Mondal N, et al. (2003) Elongation by RNA polymerase II on chromatin templates requires topoisomerase activity. Nucleic Acids Res 31(17):5016-24 | |
| Bachant J, et al. (2002) The SUMO-1 isopeptidase Smt4 is linked to centromeric cohesion through SUMO-1 modification of DNA topoisomerase II. Mol Cell 9(6):1169-82 | |
| Bhalla N, et al. (2002) Mutation of YCS4, a budding yeast condensin subunit, affects mitotic and nonmitotic chromosome behavior. Mol Biol Cell 13(2):632-45 | |
| Strumberg D, et al. (2002) Importance of the fourth alpha-helix within the CAP homology domain of type II topoisomerase for DNA cleavage site recognition and quinolone action. Antimicrob Agents Chemother 46(9):2735-46 | |
| Trigueros S and Roca J (2002) A GyrB-GyrA fusion protein expressed in yeast cells is able to remove DNA supercoils but cannot substitute eukaryotic topoisomerase II. Genes Cells 7(3):249-57 | |
| Trigueros S and Roca J (2002) Failure to relax negative supercoiling of DNA is a primary cause of mitotic hyper-recombination in topoisomerase-deficient yeast cells. J Biol Chem 277(40):37207-11 | |
| Baird CL, et al. (2001) The ATPase reaction cycle of yeast DNA topoisomerase II. Slow rates of ATP resynthesis and P(i) release. J Biol Chem 276(30):27893-8 | |
| Byl JA, et al. (2001) DNA topoisomerase II as the target for the anticancer drug TOP-53: mechanistic basis for drug action. Biochemistry 40(3):712-8 | |
| Nitiss JL, et al. (2001) Overexpression of type I topoisomerases sensitizes yeast cells to DNA damage. J Biol Chem 276(28):26708-14 | |
| Roca J (2001) Varying levels of positive and negative supercoiling differently affect the efficiency with which topoisomerase II catenates and decatenates DNA. J Mol Biol 305(3):441-50 | |
| Trigueros S and Roca J (2001) Circular minichromosomes become highly recombinogenic in topoisomerase-deficient yeast cells. J Biol Chem 276(3):2243-8 | |
| Wang H, et al. (2001) Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation. Biochemistry 40(11):3316-23 | |
| Morris SK, et al. (2000) Steady-state and rapid kinetic analysis of topoisomerase II trapped as the closed-clamp intermediate by ICRF-193. J Biol Chem 275(4):2613-8 | |
| Baird CL, et al. (1999) Topoisomerase II drives DNA transport by hydrolyzing one ATP. Proc Natl Acad Sci U S A 96(24):13685-90 | |
| Leroy D, et al. (1999) Mutations in the C-terminal domain of topoisomerase II affect meiotic function and interaction with the casein kinase 2 beta subunit. Mol Cell Biochem 191(1-2):85-95 | |
| Morris SK and Lindsley JE (1999) Yeast topoisomerase II is inhibited by etoposide after hydrolyzing the first ATP and before releasing the second ADP. J Biol Chem 274(43):30690-6 | |
| Morris SK, et al. (1999) Kinetic and thermodynamic analysis of mutant type II DNA topoisomerases that cannot covalently cleave DNA. J Biol Chem 274(6):3446-52 | |
| Olland S and Wang JC (1999) Catalysis of ATP hydrolysis by two NH(2)-terminal fragments of yeast DNA topoisomerase II. J Biol Chem 274(31):21688-94 | |
| Schultz MC (1999) Chromatin assembly in yeast cell-free extracts. Methods 17(2):161-72 | |
| Liu Q and Wang JC (1998) Identification of active site residues in the "GyrA" half of yeast DNA topoisomerase II. J Biol Chem 273(32):20252-60 | |
| Reid RJ, et al. (1998) Yeast as a model organism for studying the actions of DNA topoisomerase-targeted drugs. Biochim Biophys Acta 1400(1-3):289-300 | |
| Sabourin M, et al. (1998) A mutant yeast topoisomerase II (top2G437S) with differential sensitivity to anticancer drugs in the presence and absence of ATP. J Biol Chem 273(44):29086-92 | |
| Benedetti P, et al. (1997) Study of yeast DNA topoisomerase II and its truncation derivatives by transmission electron microscopy. J Biol Chem 272(18):12132-7 | |
| Garinther WI and Schultz MC (1997) Topoisomerase function during replication-independent chromatin assembly in yeast. Mol Cell Biol 17(7):3520-6 | |
| Rybenkov VV, et al. (1997) Simplification of DNA topology below equilibrium values by type II topoisomerases. Science 277(5326):690-3 | |
| Shaw SY and Wang JC (1997) Chirality of DNA trefoils: implications in intramolecular synapsis of distant DNA segments. Proc Natl Acad Sci U S A 94(5):1692-7 | |
| Tennyson RB and Lindsley JE (1997) Type II DNA topoisomerase from Saccharomyces cerevisiae is a stable dimer. Biochemistry 36(20):6107-14 | |
| Berger JM, et al. (1996) Structure and mechanism of DNA topoisomerase II. Nature 379(6562):225-32 | |
| Cavalli G, et al. (1996) Inactivation of topoisomerases affects transcription-dependent chromatin transitions in rDNA but not in a gene transcribed by RNA polymerase II. EMBO J 15(3):590-7 | |
| Hung F, et al. (1996) Characterization of topoisomerase II-DNA interaction and identification of a DNA-binding domain by ultraviolet laser crosslinking. FEBS Lett 380(1-2):127-32 | |



